The New Yorker writes about Merck and Vioxx
“While that kind of weighing of risk and benefit may be medically rational, in the legal arena it’s poison.” (via PointofLaw.com)
The New Yorker writes about Merck and Vioxx
Real physician voices, twice a week
Join 100,000+ subscribers. Free, and one click to unsubscribe.
More in Uncategorized
The Podcast
Latest episodes
Amazon and Uber set the bar that primary care is judged against
Why patients stop trusting doctors who listened to them
Some relationships work like medicine. Others work like a diagnosis.
Food allergies are treated differently, airline by airline
Staying salaried may now be the riskier bet for doctors
Doctors’ kids miss them, and the family builds its own fixes
Why exhaustion can make you see things that aren’t there
Why business pressure and threats ended a career she loved
Retirement isn’t the end of medicine, it’s a second act
Blaming the doctor is cheaper than fixing the record system
